WinstonWınston
Back
Stock

Oriola Oyj

0NES.L
27
Medical - Distribution · Healthcare
Price
0.75 GBp
+0.01 (+0.94%)
Market Cap
£136.0M
Exchange
London Stock Exchange
Winston Score
27
Winston is worried
Below-average fundamentals — multiple weak pillars.
Data as of Oct 10, 2026 · filings through Jun 30, 2026

§How the score breaks down

Quality
Weak
5/30
Growth
Mixed
5/20
Cash Flow
Weak
0/10
Stability
Mixed
4/10
Valuation
Data not available
0/10
Ownership
Good
10/15
Dividends
Good
3/5

27 of 100 counted points = Winston Score 27.

Track this stock — start free trial

Share count rising — dilution

+1.5% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 181.4M (2021) → 184.2M (2025)

§Winston Score History

The full picture

Oriola Oyj is a Finnish healthcare company that delivers medicines and health products to pharmacies, hospitals, and healthcare providers. It acts as a middleman — buying drugs from pharmaceutical manufacturers and distributing them to the places where patients actually get their medicine. The company operates mainly in Finland and Sweden, two of the Nordic countries in northern Europe.

Oriola makes money by taking a small margin on each product it moves through its distribution network. With a gross margin of just 3.4%, the business runs on thin profits and high volumes, which is typical for pharmaceutical distributors. Its main competitive advantage is its established logistics infrastructure and long-term contracts with pharmacy chains in the Nordics. The key risk is that regulatory changes to pharmacy pricing or drug reimbursement rules in Finland or Sweden could quickly squeeze already-thin margins, making profitability difficult to sustain.

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

-89.8% YoY

YoY Growth Rate

Revenue declining

EPS Growth

+77.1% YoY

YoY Growth Rate

EPS growth accelerating

R&D Spend

€0/ year

0.0% of revenue

Below sector average (18%)

Research and development spending

Insider Activity

38.3%ownership

→ Flat

Insider ownership roughly steady over the past year

Cash Runway

~4 years

€297M cash & investments

Quarterly Free Cash Flow

↓ Burn rate worsening

€297M cash & investments at current burn rate

Revenue declining

Oriola Oyj's revenue is actually shrinking. In a growth stock, that removes the core investment thesis. The low Winston Score here may be warranted — unless there's a turnaround story.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
0.8%
Thin — 0.8% gross margin
Profit after running costs
Operating Margin
1.2%
Thin — 1.2% operating margin
Return on the money invested
ROCE
5.8%
Weak — 5.8% return on capital

ROIC between 5% and 15%. They earn 5 to 15 cents back per year on every dollar invested.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
-41.5%
Shrinking sales (-41.5% YoY)
Profit growth
EPS YoY
N/A
Data not available
How steady the profit is
EPS Consistency
5/8 quarters
Mixed — about half the quarters showed growth

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
N/A
Data not available
Spare cash per sale
FCF Margin
-0.5%
Burning cash (-0.5%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
0.80
Moderate — manageable debt (0.80)
Covers its interest
Interest Cover
1.30x
Dangerous — barely covers interest (1.3x)

Interest coverage between 1 and 3. Profits cover interest, but with little room to spare.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
N/M
Negative earnings — P/E not meaningful
Cheaper or dearer next year
P/E vs Forward
N/A
not available
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend
Dividend Yield
4.00%
Healthy income — 4.00% yield

Generous yield. Worth checking whether the payout is sustainable.

Dividend record
Dividend Growth
-8.0%
Dividend cut (-8.0% YoY) — warning sign

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial